TriangleNCT03792633 · OUTCOME
Number of Subjects With Event-Free Survival in Patients With Newly Diagnosed VHR B-ALL or High-risk Relapse of B-ALL 1 Year After Treatment.
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of subjects
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 1 year
What was measured
Time from infusion to the first of event or censoring Events = Relapse, No Response, or Death; Censoring =Initiation of New Anticancer Therapy, Last Day of Follow-up/EOS; whichever occurs first.
Groups in this outcome
Cohort A
Patients with newly diagnosed VHR B-ALL or high-risk relapse of B-ALL
| Group | Source count |
|---|---|
| Cohort A | 52 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cohort A | 68.9 | Not reported | 56.8 | 83.5 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 56.8
- upper Limit
- 83.5
- value
- 68.9
- denoms
- counts
- group Id
- OG000
- value
- 52
- units
- Participants
- description
- Time from infusion to the first of event or censoring Events = Relapse, No Response, or Death; Censoring =Initiation of New Anticancer Therapy, Last Day of Follow-up/EOS; whichever occurs first.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients with newly diagnosed VHR B-ALL or high-risk relapse of B-ALL
- id
- OG000
- title
- Cohort A
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 1 year
- title
- Number of Subjects With Event-Free Survival in Patients With Newly Diagnosed VHR B-ALL or High-risk Relapse of B-ALL 1 Year After Treatment.
- type
- PRIMARY
- unit Of Measure
- percentage of subjects
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice